Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 34

Results For "IT"

10133 News Found

Leeford Healthcare bets Rs. 200 crore on orthopedic & mobility aids
Healthcare | January 09, 2026

Leeford Healthcare bets Rs. 200 crore on orthopedic & mobility aids

Tiger Shroff fronts ‘Fit Raho, Hit Raho’ campaign


Alkem launches innovative hair growth support therapy kit
News | January 09, 2026

Alkem launches innovative hair growth support therapy kit

The supplements are made using only vegetarian-sourced ingredients


Nimbus Therapeutics and Eli Lilly team up on novel obesity therapy
News | January 09, 2026

Nimbus Therapeutics and Eli Lilly team up on novel obesity therapy

The partnership builds on a prior collaboration between Nimbus and Lilly targeting AMPK in cardiometabolic diseases


Wockhardt files marketing authorisation application for WCK 5222 with EMA
News | January 08, 2026

Wockhardt files marketing authorisation application for WCK 5222 with EMA

WCK 5222 is the first New Chemical Entity (NCE) discovered and developed in India to be submitted for pan-European marketing authorisation


Biocon Biologics to introduce three new oncology biosimilars, eyes $75 billion market opportunity
News | January 08, 2026

Biocon Biologics to introduce three new oncology biosimilars, eyes $75 billion market opportunity

The new assets expand Biocon Biologics’ already robust oncology portfolio, which now includes 17 cancer therapies


Alzheimer’s could soon be detected with a simple finger-prick
R&D | January 08, 2026

Alzheimer’s could soon be detected with a simple finger-prick

Blood tests measuring biomarkers such as p-tau217 are emerging as accurate, accessible alternatives


Takeda & Protagonist submit FDA application for groundbreaking polycythemia vera therapy
R&D | January 08, 2026

Takeda & Protagonist submit FDA application for groundbreaking polycythemia vera therapy

The investigational subcutaneous hepcidin mimetic peptide is designed to regulate iron and red blood cell production


Arrowhead Pharmaceuticals gets green light for first-of-its-kind FCS therapy
News | January 08, 2026

Arrowhead Pharmaceuticals gets green light for first-of-its-kind FCS therapy

REDEMPLO is the first and only Health Canada-approved siRNA therapy for FCS